Global Prostate-Specific Antigen (PSA) Test Market Research Report 2023

Publisher Name :
Date: 30-Jan-2023
No. of pages: 89
Inquire Before Buying

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

Highlights

The global Prostate-Specific Antigen (PSA) Test market was valued at US$ 528.3 million in 2022 and is anticipated to reach US$ 628.6 million by 2029, witnessing a CAGR of 2.9% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate-Specific Antigen (PSA) Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate-Specific Antigen (PSA) Test.

The Prostate-Specific Antigen (PSA) Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prostate-Specific Antigen (PSA) Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate-Specific Antigen (PSA) Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Abbott

- Siemens Healthcare

- DiaSorin

- Roche

- Beckman Coulter

- PerkinElmer

- Tosoh

- Ortho Clinical

- Fujirebio

- Mediwatch (LABORIE)

- BodiTech

Segment by Type

- CLIA

- ELISA

- Other

Segment by Application

- Screening

- Post-treatment Monitoring

- Other

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prostate-Specific Antigen (PSA) Test companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Prostate-Specific Antigen (PSA) Test Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CLIA
1.2.3 ELISA
1.2.4 Other
1.3 Market by Application
1.3.1 Global Prostate-Specific Antigen (PSA) Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2018-2029)
2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Region
2.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Size by Region (2018-2023)
2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2024-2029)
2.3 Prostate-Specific Antigen (PSA) Test Market Dynamics
2.3.1 Prostate-Specific Antigen (PSA) Test Industry Trends
2.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers
2.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges
2.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue
3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2018-2023)
3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2018-2023)
3.2 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
3.4 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
3.4.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2022
3.5 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
3.6 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
3.7 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-Specific Antigen (PSA) Test Breakdown Data by Type
4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2018-2023)
4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2024-2029)
5 Prostate-Specific Antigen (PSA) Test Breakdown Data by Application
5.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2018-2023)
5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
6.2 North America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
7.2 Europe Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
9.2 Latin America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
9.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2018-2029)
10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
11.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Detail
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
11.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.2.5 Siemens Healthcare Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Detail
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
11.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.3.5 DiaSorin Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
11.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Detail
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
11.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.5.5 Beckman Coulter Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
11.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Tosoh
11.7.1 Tosoh Company Detail
11.7.2 Tosoh Business Overview
11.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
11.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.7.5 Tosoh Recent Development
11.8 Ortho Clinical
11.8.1 Ortho Clinical Company Detail
11.8.2 Ortho Clinical Business Overview
11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
11.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.8.5 Ortho Clinical Recent Development
11.9 Fujirebio
11.9.1 Fujirebio Company Detail
11.9.2 Fujirebio Business Overview
11.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
11.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.9.5 Fujirebio Recent Development
11.10 Mediwatch (LABORIE)
11.10.1 Mediwatch (LABORIE) Company Detail
11.10.2 Mediwatch (LABORIE) Business Overview
11.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
11.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.10.5 Mediwatch (LABORIE) Recent Development
11.11 BodiTech
11.11.1 BodiTech Company Detail
11.11.2 BodiTech Business Overview
11.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
11.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
11.11.5 BodiTech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CLIA
Table 3. Key Players of ELISA
Table 4. Key Players of Other
Table 5. Global Prostate-Specific Antigen (PSA) Test Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2018-2023)
Table 9. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2024-2029)
Table 11. Prostate-Specific Antigen (PSA) Test Market Trends
Table 12. Prostate-Specific Antigen (PSA) Test Market Drivers
Table 13. Prostate-Specific Antigen (PSA) Test Market Challenges
Table 14. Prostate-Specific Antigen (PSA) Test Market Restraints
Table 15. Global Prostate-Specific Antigen (PSA) Test Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Prostate-Specific Antigen (PSA) Test Market Share by Players (2018-2023)
Table 17. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2022)
Table 18. Ranking of Global Top Prostate-Specific Antigen (PSA) Test Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
Table 22. Date of Enter into Prostate-Specific Antigen (PSA) Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Prostate-Specific Antigen (PSA) Test Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2018-2023)
Table 26. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2024-2029)
Table 28. Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2018-2023)
Table 30. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2024-2029)
Table 32. North America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Prostate-Specific Antigen (PSA) Test Product
Table 50. Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Siemens Healthcare Company Detail
Table 53. Siemens Healthcare Business Overview
Table 54. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product
Table 55. Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 56. Siemens Healthcare Recent Development
Table 57. DiaSorin Company Detail
Table 58. DiaSorin Business Overview
Table 59. DiaSorin Prostate-Specific Antigen (PSA) Test Product
Table 60. DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 61. DiaSorin Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Prostate-Specific Antigen (PSA) Test Product
Table 65. Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Beckman Coulter Company Detail
Table 68. Beckman Coulter Business Overview
Table 69. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product
Table 70. Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 71. Beckman Coulter Recent Development
Table 72. PerkinElmer Company Detail
Table 73. PerkinElmer Business Overview
Table 74. PerkinElmer Prostate-Specific Antigen (PSA) Test Product
Table 75. PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 76. PerkinElmer Recent Development
Table 77. Tosoh Company Detail
Table 78. Tosoh Business Overview
Table 79. Tosoh Prostate-Specific Antigen (PSA) Test Product
Table 80. Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 81. Tosoh Recent Development
Table 82. Ortho Clinical Company Detail
Table 83. Ortho Clinical Business Overview
Table 84. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product
Table 85. Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 86. Ortho Clinical Recent Development
Table 87. Fujirebio Company Detail
Table 88. Fujirebio Business Overview
Table 89. Fujirebio Prostate-Specific Antigen (PSA) Test Product
Table 90. Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 91. Fujirebio Recent Development
Table 92. Mediwatch (LABORIE) Company Detail
Table 93. Mediwatch (LABORIE) Business Overview
Table 94. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product
Table 95. Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 96. Mediwatch (LABORIE) Recent Development
Table 97. BodiTech Company Detail
Table 98. BodiTech Business Overview
Table 99. BodiTech Prostate-Specific Antigen (PSA) Test Product
Table 100. BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2018-2023) & (US$ Million)
Table 101. BodiTech Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Prostate-Specific Antigen (PSA) Test Market Share by Type: 2022 VS 2029
Figure 3. CLIA Features
Figure 4. ELISA Features
Figure 5. Other Features
Figure 6. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2022 VS 2029
Figure 8. Screening Case Studies
Figure 9. Post-treatment Monitoring Case Studies
Figure 10. Other Case Studies
Figure 11. Prostate-Specific Antigen (PSA) Test Report Years Considered
Figure 12. Global Prostate-Specific Antigen (PSA) Test Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Prostate-Specific Antigen (PSA) Test Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Prostate-Specific Antigen (PSA) Test Market Share by Region: 2022 VS 2029
Figure 15. Global Prostate-Specific Antigen (PSA) Test Market Share by Players in 2022
Figure 16. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2022
Figure 18. North America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2029)
Figure 20. United States Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2029)
Figure 24. Germany Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Share by Region (2018-2029)
Figure 32. China Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2029)
Figure 40. Mexico Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Share by Country (2018-2029)
Figure 44. Turkey Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 47. Siemens Healthcare Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 48. DiaSorin Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 50. Beckman Coulter Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 51. PerkinElmer Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 52. Tosoh Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 53. Ortho Clinical Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 54. Fujirebio Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 55. Mediwatch (LABORIE) Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 56. BodiTech Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs